Skip to main content
Earnings Labs
Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc. (FATE) Earnings

NASDAQ·Healthcare·Biotechnology

$2.07

+5.08%

Mkt Cap $230.79M

EPS — Estimate vs Actual

Mkt Cap

$230.79M

P/E

Fwd P/E

P/S

36.54

Rev TTM

EPS TTM

-$1.09